Document Type

Article

Publication Date

5-2014

Comments

This article has been peer reviewed. It is the authors' final version prior to publication in Nature Reviews Urology, Volume 11, Issue 5, May 2014, Pages 253-254.

The published version is available at DOI: 10.1038/nrurol.2014.90. Copyright © Nature Publishing Group

Abstract

Two major trials have been performed to determine the effect of 5α-reductase inhibitors on subsequent diagnoses of prostate cancer. Both trials showed that high alcohol intake significantly increased prostate cancer risk among men allocated to the treatment arms. The recommendation that patients eliminate alcohol when taking 5α-reductase inhibitors seems appropriate.

Included in

Urology Commons

Share

COinS